Reuters - Thermo Fisher Nears $13bn Life Tech Deal
Thermo Fisher Scientific is nearing a deal to buy genetic testing equipment maker Life Technologies for close to $13 billion, writes Reuters. Life Technologies' board chose Thermo Fisher over Sigma-Aldrich Corp, a maker of chemicals for research laboratories, and a private equity consortium consisting of Blackstone Group, Carlyle Group, KKR and Temasek Holdings, writes Reuters.




